Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.
about
Genomic analysis to guide choice of treatment for smoking cessationPharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trialLung cancer and occupation in a population-based case-control studyMicrosomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human diseasePutative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysisReview of the Gene-Environment Interaction Literature in Cancer: What Do We Know?Use of multiple imputation to correct for bias in lung cancer incidence trends by histologic subtype.Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer riskErlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analyses.Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populationsUGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.An Improved Version of Logistic Bayesian LASSO for Detecting Rare Haplotype-Environment Interactions with Application to Lung CancerContribution of environment and genetics to pancreatic cancer susceptibilityA gene expression signature from peripheral whole blood for stage I lung adenocarcinoma.Prevalence of at-risk genotypes for genotoxic effects decreases with age in a randomly selected population in Flanders: a cross sectional study.Association study of xenobiotic detoxication and repair genes with malignant brain tumors in children.GSTM1 and GSTT1 copy numbers and mRNA expression in lung cancerEstrogen metabolism within the lung and its modulation by tobacco smoke.Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels.Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.Polymorphisms of NRF2 gene correlated with decreased FEV1 in lung cancers of smokers.Chronic obstructive pulmonary disease and lung cancer: new molecular insights.Novel insights into etiologies of leukemia: a HuGE review and meta-analysis of CYP1A1 polymorphisms and leukemia risk.DNA adducts and combinations of multiple lung cancer at-risk alleles in environmentally exposed and smoking subjects.Race and ethnicity in cancer therapy: what have we learned?Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: an updated meta-analysis.Association between myeloperoxidase G-463A polymorphism and lung cancer risk.Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis.Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.Influence of single-nucleotide polymorphisms on deferasirox C trough levels and effectiveness.Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.CYP1A1, GCLC, AGT, AGTR1 gene-gene interactions in community-acquired pneumonia pulmonary complications.Association between MPO 463G>A polymorphism and risk of lung cancer: a meta-analysis.Association between CYP2A6 genetic polymorphisms and lung cancer: a meta-analysis of case-control studies.Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis.Modeling Unobserved Heterogeneity in Susceptibility to Ambient Benzo[a]pyrene Concentration among Children with Allergic Asthma Using an Unsupervised Learning Algorithm.Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.
P2860
Q24188234-FCCAC72A-E0E5-4E07-9306-2F48C44947BAQ27012807-010E2247-B5A6-440B-BF86-F8ABE00A0C0AQ28285393-BB80BA22-3B3C-4DCF-82BE-5E6EB0C8586FQ28393149-E912FDD2-D863-4DB8-932D-224A802F568CQ28608628-FCDCFEAB-BAF9-4749-922E-96B149688BB1Q28741808-15090678-07A1-4524-8617-CAAD033FBD5CQ30251624-7D43D3B4-35BF-47B9-9A5F-3264C493C422Q30585673-7E51F240-21C2-4B65-9478-8DE2C378BF92Q33759681-481A9FA6-28E7-48BB-8417-3DC11E22DE67Q34266864-6C5ACA99-52DA-46A5-9AF2-0E998906E421Q34306305-1207C27F-899D-40F5-9BDF-6CBA95B84272Q34307589-C4BED5C1-B89B-49DB-B23B-CBDDF3A04401Q34918092-9565F0DB-F6A0-49FB-8EAD-7BAAC51306A9Q34964392-B4960179-047B-4EF5-AAB9-A0555FE81303Q35093844-5DDFEF01-CDBC-449A-8A49-6E69A281D509Q35126601-B3690AA0-24E9-441B-80E8-50F2EAE3E199Q35281526-1609F880-F31D-47E4-9E1E-0CDA47BF466EQ35373298-95F21DE6-D7E4-4488-A6F2-EF5B1360B02FQ35944395-EBF16964-8D28-45F7-88CD-9C1E4FA8F9A8Q36037230-4283F03D-8A68-495B-AFBB-2E49F71D5532Q36740713-B13B7856-38DC-477C-9A96-E19798583DFBQ36978267-876681FB-8F78-48FB-A64C-24B4D42E9CB0Q37163230-5B3B39B5-DB5D-4E2E-8C34-A64F3CD94C59Q37567653-9B45DDDF-3148-4F4C-BC14-D65FF650B46AQ37856648-7310AF90-2B13-4E70-8F6A-25C44566EE89Q38109462-96878A04-6B0E-485D-86CB-2F91C8664020Q38116805-1E30007B-86A3-420D-88C7-F256AB7E4383Q38178095-CC0615BA-15D4-494B-A059-220C801F3EFCQ38225692-D806851A-5BF6-43B5-BE49-25D63E5F7289Q39367333-C0205D7E-0216-44E9-91D6-3FCB16819A27Q40632689-76B8FAD2-6E50-4ECF-BF4C-8ED18D7D3DC7Q41206586-C54F331B-596C-4083-B4E0-F8D9CEB3D2E0Q41687355-0FF395EC-A43B-4464-9E34-5A493315C04FQ41727091-BD3CA13A-2E00-4660-88BF-C966DFA26250Q42620068-6FDD23B0-D9E8-4D94-9D58-897B3A92EBDEQ43569589-CF51B06E-AD79-4098-B6CA-3EC448A015DDQ43580817-8111FBE6-C8A7-44BD-A706-AA646C5BAD70Q44849553-7FE85B4C-EEAC-45D1-AA90-AB24C9850EE1Q47565928-CC1469CE-BCA5-4F50-9EDC-CC1123704A8AQ48015634-225CBFDA-6BF5-40FF-BBA3-E34B6E30A240
P2860
Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phase I metabolic genes and ri ...... morphisms and mRNA expression.
@ast
Phase I metabolic genes and ri ...... morphisms and mRNA expression.
@en
type
label
Phase I metabolic genes and ri ...... morphisms and mRNA expression.
@ast
Phase I metabolic genes and ri ...... morphisms and mRNA expression.
@en
prefLabel
Phase I metabolic genes and ri ...... morphisms and mRNA expression.
@ast
Phase I metabolic genes and ri ...... morphisms and mRNA expression.
@en
P2093
P2860
P50
P1433
P1476
Phase I metabolic genes and ri ...... morphisms and mRNA expression.
@en
P2093
Alisa M Goldstein
Dario Consonni
Jay H Lubin
Laurie Burdette
Lynn R Goldin
Margaret A Tucker
Maria Teresa Landi
Melissa Rotunno
Neil E Caporaso
P2860
P356
10.1371/JOURNAL.PONE.0005652
P407
P50
P577
2009-05-21T00:00:00Z